![Walid Abi-Saab](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Walid Abi-Saab
Chief Tech/Sci/R&D Officer at
UNIQURE N.V.
Net worth: 7 M $ as of 2026-06-29
Profile
Dr. Walid Abi-Saab, MD, is a Chief Medical Officer at Galapagos NV. Dr. Abi-Saab was previously employed as a Group Vice President-Clinical Development by Shire Plc and an Assistant Professor-Psychiatry & Neurosurgery by Yale School of Medicine. He received his doctorate degree from the University of Saint Joseph (Macau).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UNIQURE N.V. 0.24% | 2026-06-29 | 148,235 ( 0.24% ) | 7 M $ | 2026-06-29 |
Walid Abi-Saab active positions
| Companies | Position | Start |
|---|---|---|
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 2023-06-25 |
Former positions of Walid Abi-Saab
| Companies | Position | End |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Chief Tech/Sci/R&D Officer | 2022-12-30 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Walid Abi-Saab
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
American University of Beirut
 American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Saint-Joseph
 Université Saint-Joseph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Walid Abi-Saab
